Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra L Harper

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Scientific Reports|October 5, 2018
CLIC1 and CLIC4 complement CA125 as a diagnostic biomarker panel for all subtypes of epithelial ovarian cancerBipradeb Singha, Sandra L Harper, Aaron R Goldman, et al.
Journal of Molecular Biology|May 22, 2007
The structurally disordered KRAB repression domain is incorporated into a protease resistant core upon binding to KAP-1-RBCC domainHongzhuang Peng, Lisa C Gibson, Allan D Capili, et al.
Cancer Discovery|November 4, 2022
Targeting UGCG Overcomes Resistance to Lysosomal Autophagy InhibitionVaibhav Jain, Sandra L Harper, Amanda M Versace, et al.
The Journal of Clinical Investigation|February 16, 2023
Lysosomal lipid peroxidation regulates tumor immunityMonika Bhardwaj, Jennifer J Lee, Amanda M Versace, et al.
JCI Insight|October 24, 2022
PPT1 inhibition enhances the antitumor activity of anti-PD-1 antibody in melanomaGaurav Sharma, Rani Ojha, Estela Noguera-Ortega, et al.
JCI Insight|August 12, 2020
PPT1 inhibition enhances the antitumor activity of anti-PD-1 antibody in melanomaGaurav Sharma, Rani Ojha, Estela Noguera-Ortega, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Scientific Reports|October 5, 2018
CLIC1 and CLIC4 complement CA125 as a diagnostic biomarker panel for all subtypes of epithelial ovarian cancerBipradeb Singha, Sandra L Harper, Aaron R Goldman, et al.
Journal of Molecular Biology|May 22, 2007
The structurally disordered KRAB repression domain is incorporated into a protease resistant core upon binding to KAP-1-RBCC domainHongzhuang Peng, Lisa C Gibson, Allan D Capili, et al.
Cancer Discovery|November 4, 2022
Targeting UGCG Overcomes Resistance to Lysosomal Autophagy InhibitionVaibhav Jain, Sandra L Harper, Amanda M Versace, et al.
The Journal of Clinical Investigation|February 16, 2023
Lysosomal lipid peroxidation regulates tumor immunityMonika Bhardwaj, Jennifer J Lee, Amanda M Versace, et al.
JCI Insight|October 24, 2022
PPT1 inhibition enhances the antitumor activity of anti-PD-1 antibody in melanomaGaurav Sharma, Rani Ojha, Estela Noguera-Ortega, et al.
JCI Insight|August 12, 2020
PPT1 inhibition enhances the antitumor activity of anti-PD-1 antibody in melanomaGaurav Sharma, Rani Ojha, Estela Noguera-Ortega, et al.
Pageof 2